The role of interleukin-1 receptor-associated kinases in Vogt-Koyanagi-Harada disease

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Sun, Min ^a,b   Yang, Peizeng ^b   Du, Liping ^b   Yang, Yan ^b   Ye, Jian ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1 INHIBITOR; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 4; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 4 INHIBITOR; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 1BETA; MESSENGER RNA; PHOSPHOTRANSFERASE INHIBITOR; STAT1 PROTEIN; STAT3 PROTEIN; UNCLASSIFIED DRUG; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE; IRAK4 PROTEIN, HUMAN; MONOCLONAL ANTIBODY;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; ENZYME INHIBITION; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MALE; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PURIFICATION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; T LYMPHOCYTE ACTIVATION; TRANSCRIPTION INITIATION; VOGT KOYANAGI SYNDROME; ANTAGONISTS AND INHIBITORS; CASE CONTROL STUDY; CD4 LYMPHOCYTE COUNT; DRUG EFFECTS; GENE EXPRESSION; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MENINGOENCEPHALITIS; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; YOUNG ADULT;

ADULT; ANTIBODIES, MONOCLONAL; CASE-CONTROL STUDIES; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; GENE EXPRESSION; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; INTERLEUKIN-17; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; NF-KAPPA B; RNA, MESSENGER; STAT1 TRANSCRIPTION FACTOR; STAT3 TRANSCRIPTION FACTOR; UVEOMENINGOENCEPHALITIC SYNDROME; YOUNG ADULT;

EID: 84898657461     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0093214     Document Type: Article

References (30)

1. Cao Z, Henzel WJ, Gao X (1996) IRAK: a kinase associated with the interleuk (Pubitemid 26075229)
2. Li S, Strelow A, Fontana EJ, Wesche H (2002) IRAK-4: a novel member of the IRAK family with the properties of an IRAK-kinase. Proc Natl Acad Sci U S A 99: 5567-5572. (Pubitemid 34411589)
3. Gottipati S, Rao NL, Fung-Leung WP (2008) IRAK1: a critical signaling mediator of innate immunity. Cell Signal 20: 269-276.
4. Medzhitov R, Preston-Hurlburt P, Kopp E, Stadlen A, Chen C, et al. (1998) MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol Cell 2: 253-258. (Pubitemid 128373651)
5. Takeda K, Akira S (2004) TLR signaling pathways. Semin Immunol 16: 3-9. (Pubitemid 38147427)
6. Muzio M, Natoli G, Saccani S, Levrero M, Mantovani A (1998) The human toll signaling pathway: divergence of nuclear factor kappaB and JNK/SAPK activation upstream of tumor necrosis factor receptor-associated factor 6 (TRAF6). J Exp Med 187: 2097-2101. (Pubitemid 28285580)
7. Wang Z, Wesche H, Stevens T, Walker N, Yeh WC (2009) IRAK-4 inhibitors for inflammation. Curr Top Med Chem 9: 724-737.
8. Picard C, Puel A, Bonnet M, Ku CL, Bustamante J, et al. (2003) Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science 299: 2076-2079. (Pubitemid 36383736)
9. Ku CL, von Bernuth H, Picard C, Zhang SY, Chang HH, et al. (2007) Selective predisposition to bacterial infections in IRAK-4-deficient children: IRAK-4-dependent TLRs are otherwise redundant in protective immunity. J Exp Med 204: 2407-2422. (Pubitemid 47529326)
10. Jacob CO, Zhu J, Armstrong DL, Yan M, Han J, et al. (2009) Identification of IRAK1 as a risk gene with critical role in the pathogenesis of systemic lupus erythematosus. Proc Natl Acad Sci U S A 106: 6256-6261.
11. Zhai Y, Xu K, Leng RX, Cen H, Wang W, et al. (2013) Association of interleukin-1 receptor-associated kinase (IRAK1) gene polymorphisms (rs3027898, rs1059702) with systemic lupus erythematosus in a Chinese Han population. Inflamm Res.
12. Robinson D, Shibuya K, Mui A, Zonin F, Murphy E, et al. (1997) IGIF does not drive Th1 development but synergizes with IL-12 for interferon-gamma production and activates IRAK and NFkappaB. Immunity 7: 571-581. (Pubitemid 27508708)
13. Bykhovskaya I, Thorne JE, Kempen JH, Dunn JP, Jabs DA (2005) Vogt-Koyanagi-Harada disease: clinical outcomes. Am J Ophthalmol 140: 674-678.
14. Rao NA, Gupta A, Dustin L, Chee SP, Okada AA, et al. (2010) Frequency of distinguishing clinical features in Vogt-Koyanagi-Harada disease. Ophthalmology 117: 591-599, 599 e591.
15. Yang P, Zhang Z, Zhou H, Li B, Huang X, et al. (2005) Clinical patterns and characteristics of uveitis in a tertiary center for uveitis in China. Curr Eye Res 30: 943-948. (Pubitemid 43154688)
16. El-Asrar AM, Struyf S, Kangave D, Al-Obeidan SS, Opdenakker G, et al. (2011) Cytokine profiles in aqueous humor of patients with different clinical entities of endogenous uveitis. Clin Immunol 139: 177-184.
17. Read RW, Holland GN, Rao NA, Tabbara KF, Ohno S, et al. (2001) Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol 131: 647-652. (Pubitemid 32422124)
18. Noble A, Leggat JA, Inderberg EM (2003) CD8+ immunoregulatory cells in the graft-versus-host reaction: CD8 T cells activate dendritic cells to secrete interleukin-12/interleukin-18 and induce T helper 1 autoantibody. Immunology 109: 476-486. (Pubitemid 36930162)
19. Greene CM, Meachery G, Taggart CC, Rooney CP, Coakley R, et al. (2000) Role of IL-18 in CD4+ T lymphocyte activation in sarcoidosis. J Immunol 165: 4718-4724.
20. Ben-Sasson SZ, Hu-Li J, Quiel J, Cauchetaux S, Ratner M, et al. (2009) IL-1 acts directly on CD4 T cells to enhance their antigen-driven expansion and differentiation. Proc Natl Acad Sci U S A 106: 7119-7124.
21. Yamamoto Y, Gaynor RB (2001) Role of the NF-kappaB pathway in the pathogenesis of human disease states. Curr Mol Med 1: 287-296. (Pubitemid 33773312)
22. Hayden MS, West AP, Ghosh S (2006) NF-kappaB and the immune response. Oncogene 25: 6758-6780.
23. Egwuagu CE (2009) STAT3 in CD4+ T helper cell differentiation and inflammatory diseases. Cytokine 47: 149-156.
24. Rosenbaum JT, Woods A, Kezic J, Planck SR, Rosenzweig HL (2011) Contrasting ocular effects of local versus systemic endotoxin. Invest Ophthalmol Vis Sci 52: 6472-6477.
25. Chi W, Yang P, Li B, Wu C, Jin H, et al. (2007) IL-23 promotes CD4+ T cells to produce IL-17 in Vogt-Koyanagi-Harada disease. J Allergy Clin Immunol 119: 1218-1224. (Pubitemid 46667160)
26. Li B, Yang P, Zhou H, Huang X, Jin H, et al. (2005) Upregulation of T-bet expression in peripheral blood mononuclear cells during Vogt-Koyanagi-Harada disease. Br J Ophthalmol 89: 1410-1412. (Pubitemid 41527370)
27. Hayden MS, Ghosh S (2011) NF-kappaB in immunobiology. Cell Res 21: 223-244.
28. Haseeb A, Chen D, Haqqi TM (2013) Delphinidin inhibits IL-1beta-induced activation of NF-kappaB by modulating the phosphorylation of IRAK-1(Ser376) in human articular chondrocytes. Rheumatology (Oxford) 52: 998-1008.
29. Bromberg J, Darnell JE Jr (2000) The role of STATs in transcriptional control and their impact on cellular function. Oncogene 19: 2468-2473. (Pubitemid 30339202)
30. Glimcher LH, Townsend MJ, Sullivan BM, Lord GM (2004) Recent developments in the transcriptional regulation of cytolytic effector cells. Nat Rev Immunol 4: 900-911. (Pubitemid 39490765)